30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Eledon Pharmaceuticals Inc (ELDN)

Track

Stock chart
Ticker: ELDN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BVF PARTNERS L P/IL
3 purchases — total 0 USD
Buy 5 May 2023
Value US$4,217,410.05 | Price 34.15 | Shares 75,799
Buy 5 May 2023
Value US$4,019,283.38 | Price 432.71 | Shares 95,567
Buy 5 May 2023
Value US$0.00 | Price 0.00 | Shares 1,055,445
Buy 23 Nov 2022
Value US$2,617,448.14 | Price 388.65 | Shares 97,176
Buy 20 Dec 2021
Value US$8,960.00 | Price 4.48 | Shares 2,000
Buy 11 Jun 2021
Value US$88,700.00 | Price 8.87 | Shares 10,000
Buy 9 Jun 2021
Value US$24,030.00 | Price 8.01 | Shares 3,000
Sale 2 Dec 2020
Value US$2,229,120.00 | Price 21.60 | Shares 103,200
Buy 30 Oct 2020
Value US$232,460.27 | Price 25.55 | Shares 9,098
Buy 30 Oct 2020
Value US$392,610.00 | Price 26.17 | Shares 15,000
Sale 30 Oct 2020
Value US$729.54 | Price 27.02 | Shares 27
Buy 30 Oct 2020
Value US$334,926.02 | Price 25.88 | Shares 12,942
Sale 30 Oct 2020
Value US$344,829.24 | Price 26.64 | Shares 12,942
Buy 30 Oct 2020
Value US$397,236.00 | Price 26.48 | Shares 15,000
Buy 30 Oct 2020
Value US$103,892.00 | Price 25.97 | Shares 4,000
Buy 30 Oct 2020
Value US$760,426.90 | Price 24.53 | Shares 31,000
Buy 30 Oct 2020
Value US$120,162.50 | Price 24.03 | Shares 5,000
Sale 21 May 2019
Value US$5,613.78 | Price 1.91 | Shares 2,937
Sale 21 May 2019
Value US$2,022.26 | Price 1.91 | Shares 1,058
Sale 21 May 2019
Value US$3,658.42 | Price 1.91 | Shares 1,914
Sale 20 May 2019
Value US$22,952.68 | Price 1.96 | Shares 11,701
Sale 20 May 2019
Value US$8,274.03 | Price 1.96 | Shares 4,218
Sale 20 May 2019
Value US$14,953.28 | Price 1.96 | Shares 7,623
Buy 2 May 2019
Value US$2,003,232.40 | Price 3.10 | Shares 646,204
Buy 2 May 2019
Value US$2,003,232.40 | Price 3.10 | Shares 646,204
Sale 30 Apr 2019
Value US$540.00 | Price 2.70 | Shares 200
Buy 12 Sep 2018
Value US$83,476.01 | Price 5.02 | Shares 16,632
Buy 11 Sep 2018
Value US$77,670.69 | Price 4.56 | Shares 17,048
Buy 5 Sep 2018
Value US$3,192.63 | Price 3.97 | Shares 805
Buy 10 May 2017
Value US$589,000.41 | Price 9.99 | Shares 58,959
Buy 10 May 2017
Value US$110,998.89 | Price 9.99 | Shares 11,111
Buy 10 May 2017
Value US$99,999.90 | Price 9.99 | Shares 10,010
Buy 15 Mar 2016
Value US$45,920.00 | Price 5.74 | Shares 8,000
Buy 11 Nov 2015
Value US$33,750.00 | Price 11.25 | Shares 3,000
Planned sale 21 Sep 2015
Value US$189,135.00 | Price 14.01 | Shares 13,500
Planned sale 29 Jul 2015
Value US$7,726.80 | Price 13.70 | Shares 564
Planned sale 28 Jul 2015
Value US$164,400.00 | Price 13.70 | Shares 12,000
Sale 15 Jul 2015
Value US$50,844.03 | Price 14.26 | Shares 3,566
Sale 14 Jul 2015
Value US$401,477.01 | Price 14.41 | Shares 27,861
Sale 13 Jul 2015
Value US$292,717.42 | Price 14.20 | Shares 20,611
Planned sale 29 Jun 2015
Value US$109,600.00 | Price 13.70 | Shares 8,000
Planned sale 26 Jun 2015
Value US$110,640.00 | Price 13.83 | Shares 8,000
Planned sale 24 Jun 2015
Value US$4,260.00 | Price 14.20 | Shares 300
Planned sale 23 Jun 2015
Value US$93,800.00 | Price 14.00 | Shares 6,700
Planned sale 22 Jun 2015
Value US$28,040.00 | Price 14.02 | Shares 2,000
Sale 16 Jun 2015
Value US$15,982.40 | Price 14.27 | Shares 1,120
Sale 12 Jun 2015
Value US$84,049.80 | Price 14.20 | Shares 5,919
Sale 11 Jun 2015
Value US$395,825.00 | Price 14.20 | Shares 27,875
Sale 19 Mar 2015
Value US$669,044.50 | Price 14.50 | Shares 46,141
Sale 18 Mar 2015
Value US$43,500.00 | Price 14.50 | Shares 3,000
Buy 22 Sep 2014
Value US$3,562,500.00 | Price 15.00 | Shares 237,500
Buy 22 Sep 2014
Value US$4,875,000.00 | Price 15.00 | Shares 325,000
Buy 22 Sep 2014
Value US$5,437,500.00 | Price 15.00 | Shares 362,500
Buy 22 Sep 2014
Value US$2,250,000.00 | Price 15.00 | Shares 150,000
Sale 15 Jun 2014
Value US$209,833.40 | Price 14.20 | Shares 14,777
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-09 2023-05-05 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
75,799
34.15
US$4,217,410 		75,799 34.15 US$4,217,410
2023-05-09 2023-05-05 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
95,567
432.71
US$4,019,283 		95,567 432.71 US$4,019,283
2023-05-09 2023-05-05 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
97,162
261.41
US$222,228 		97,162 261.41 US$222,228
2022-11-23 2022-11-23 B Purchase
1.0
Perrin Steven

President

Executive Director
1,000 +inf%
2.60
US$2,597 		1,000 +inf% 2.60 US$2,597
2021-12-21 2021-12-20 B Purchase
1.2
Gros David-Alexandre C

Chief Executive Officer

Executive Director
2,000 +28.6%
4.48
US$8,960 		2,000 +28.6% 4.48 US$8,960
2021-06-14 2021-06-11 B Purchase
0.7
Little Paul Sean

CHIEF FINANCIAL OFFICER

Officer
10,000 +inf%
8.87
US$88,700 		10,000 +inf% 8.87 US$88,700
2021-06-10 2021-06-09 B Purchase
1.2
Gros David-Alexandre C

Chief Executive Officer

Executive Director
3,000 +inf%
8.01
US$24,030 		3,000 +inf% 8.01 US$24,030
2020-12-04 2020-12-02 S Sale
3.9
OrbiMed Israel GP Ltd.
Large shareholder
103,200 -58.4%
21.60
US$2,229,120 		103,200 -58.4% 21.60 US$2,229,120
2020-11-06 2020-10-30 B Purchase
1.0
Logos Global Management LP
Large shareholder
9,098 +4.2%
25.55
US$232,460 		9,098 +4.2% 25.55 US$232,460
2020-11-06 2020-10-30 B Purchase
1.0
Logos Global Management LP
Large shareholder
15,000 +7.5%
26.17
US$392,610 		15,000 +7.5% 26.17 US$392,610
2020-11-06 2020-10-30 S Sale
1.0
Logos Global Management LP
Large shareholder
27 -0.0%
27.02
US$730 		27 -0.0% 27.02 US$730
2020-11-06 2020-10-30 B Purchase
1.0
Logos Global Management LP
Large shareholder
12,942 +6.9%
25.88
US$334,926 		12,942 +6.9% 25.88 US$334,926
2020-11-06 2020-10-30 S Sale
1.0
Logos Global Management LP
Large shareholder
12,942 -6.5%
26.64
US$344,829 		12,942 -6.5% 26.64 US$344,829
2020-11-06 2020-10-30 B Purchase
1.0
Logos Global Management LP
Large shareholder
15,000 +8.1%
26.48
US$397,236 		15,000 +8.1% 26.48 US$397,236
2020-11-06 2020-10-30 B Purchase
1.0
Logos Global Management LP
Large shareholder
4,000 +2.2%
25.97
US$103,892 		4,000 +2.2% 25.97 US$103,892
2020-11-06 2020-10-30 B Purchase
1.0
Logos Global Management LP
Large shareholder
31,000 +20.7%
24.53
US$760,427 		31,000 +20.7% 24.53 US$760,427
2020-11-06 2020-10-30 B Purchase
1.0
Logos Global Management LP
Large shareholder
5,000 +3.4%
24.03
US$120,162 		5,000 +3.4% 24.03 US$120,162
2019-05-22 2019-05-21 S Sale
3.6
FLESHER GREGORY J.

Chief Executive Officer
2,937 -1.8%
1.91
US$5,614 		2,937 -1.8% 1.91 US$5,614
2019-05-22 2019-05-21 S Sale
3.6
Kuwahara Jon

See Remarks
1,058 -15.0%
1.91
US$2,022 		1,058 -15.0% 1.91 US$2,022
2019-05-22 2019-05-21 S Sale
3.6
TURKEL CATHERINE C.

President
1,914 -2.1%
1.91
US$3,658 		1,914 -2.1% 1.91 US$3,658
2019-05-22 2019-05-20 S Sale
3.6
FLESHER GREGORY J.

Chief Executive Officer
11,701 -6.8%
1.96
US$22,953 		11,701 -6.8% 1.96 US$22,953
2019-05-22 2019-05-20 S Sale
3.6
Kuwahara Jon

See Remarks
4,218 -37.5%
1.96
US$8,274 		4,218 -37.5% 1.96 US$8,274
2019-05-22 2019-05-20 S Sale
3.6
TURKEL CATHERINE C.

President
7,623 -7.8%
1.96
US$14,953 		7,623 -7.8% 1.96 US$14,953
2019-05-06 2019-05-02 B Purchase
Chimovits Erez
646,204 +25.5%
3.10
US$2,003,232 		646,204 +25.5% 3.10 US$2,003,232
2019-05-06 2019-05-02 B Purchase
3.9
OrbiMed Israel GP Ltd.
Large shareholder
646,204 +25.5%
3.10
US$2,003,232 		646,204 +25.5% 3.10 US$2,003,232
2019-05-02 2019-04-30 S Sale
3.3
LIFESCI INDEX PARTNERS LLC
Large shareholder
200 -0.0%
2.70
US$540 		200 -0.0% 2.70 US$540
2018-09-13 2018-09-12 B Purchase TURKEL CATHERINE C.

President

Officer
16,632 +27.0%
5.02
US$83,476 		16,632 +27.0% 5.02 US$83,476
2018-09-13 2018-09-11 B Purchase TURKEL CATHERINE C.

President

Officer
17,048 +38.3%
4.56
US$77,671 		17,048 +38.3% 4.56 US$77,671
2018-09-07 2018-09-05 B Purchase TURKEL CATHERINE C.

President

Officer
805 +inf%
3.97
US$3,193 		805 +inf% 3.97 US$3,193
2017-05-11 2017-05-10 B Purchase FLESHER GREGORY J.

Chief Executive Officer

Executive Director
58,959 +103.6%
9.99
US$589,000 		58,959 +103.6% 9.99 US$589,000
2017-05-11 2017-05-10 B Purchase TURKEL CATHERINE C.

Chief Development Officer

Officer
11,111 +82.9%
9.99
US$110,999 		11,111 +82.9% 9.99 US$110,999
2017-05-11 2017-05-10 B Purchase OCAMPO CHRISTINE

See Remarks

Officer
10,010 +86.4%
9.99
US$100,000 		10,010 +86.4% 9.99 US$100,000
2016-03-15 2016-03-15 B Purchase Buckley Stephen Jr. Non-Executive Director
8,000 +266.7%
5.74
US$45,920 		8,000 +266.7% 5.74 US$45,920
2015-11-12 2015-11-11 B Purchase Buckley Stephen Jr. Non-Executive Director
3,000 +inf%
11.25
US$33,750 		3,000 +inf% 11.25 US$33,750
2015-09-22 2015-09-21 PlS Planned sale McBride John S.

Chief Operating Officer

Officer
13,500 -100.0%
14.01
US$189,135 		13,500 -100.0% 14.01 US$189,135
2015-07-30 2015-07-29 PlS Planned sale Morrison Jodie Pope

President and CEO

Executive Director
564 -2.8%
13.70
US$7,727 		564 -2.8% 13.70 US$7,727
2015-07-30 2015-07-28 PlS Planned sale Morrison Jodie Pope

President and CEO

Executive Director
12,000 -38.0%
13.70
US$164,400 		12,000 -38.0% 13.70 US$164,400
2015-07-17 2015-07-15 S Sale Novartis Bioventures Ltd Large shareholder
3,566 -0.1%
14.26
US$50,844 		3,566 -0.1% 14.26 US$50,844
2015-07-15 2015-07-14 S Sale Novartis Bioventures Ltd Large shareholder
27,861 -0.6%
14.41
US$401,477 		27,861 -0.6% 14.41 US$401,477
2015-07-15 2015-07-13 S Sale Novartis Bioventures Ltd Large shareholder
20,611 -0.5%
14.20
US$292,717 		20,611 -0.5% 14.20 US$292,717
2015-06-30 2015-06-29 PlS Planned sale Morrison Jodie Pope

President and CEO

Executive Director
8,000 -45.6%
13.70
US$109,600 		8,000 -45.6% 13.70 US$109,600
2015-06-30 2015-06-26 PlS Planned sale Morrison Jodie Pope

President and CEO

Executive Director
8,000 -45.6%
13.83
US$110,640 		8,000 -45.6% 13.83 US$110,640
2015-06-24 2015-06-24 PlS Planned sale McBride John S.

Chief Operating Officer

Officer
300 -100.0%
14.20
US$4,260 		300 -100.0% 14.20 US$4,260
2015-06-24 2015-06-23 PlS Planned sale McBride John S.

Chief Operating Officer

Officer
6,700 -100.0%
14.00
US$93,800 		6,700 -100.0% 14.00 US$93,800
2015-06-24 2015-06-22 PlS Planned sale McBride John S.

Chief Operating Officer

Officer
2,000 -100.0%
14.02
US$28,040 		2,000 -100.0% 14.02 US$28,040
2015-06-18 2015-06-16 S Sale Novartis Bioventures Ltd Large shareholder
1,120 -0.0%
14.27
US$15,982 		1,120 -0.0% 14.27 US$15,982
2015-06-16 2015-06-12 S Sale Novartis Bioventures Ltd Large shareholder
5,919 -0.1%
14.20
US$84,050 		5,919 -0.1% 14.20 US$84,050
2015-06-12 2015-06-11 S Sale Novartis Bioventures Ltd Large shareholder
27,875 -0.6%
14.20
US$395,825 		27,875 -0.6% 14.20 US$395,825
2015-03-20 2015-03-19 S Sale Novartis Bioventures Ltd Large shareholder
46,141 -1.0%
14.50
US$669,044 		46,141 -1.0% 14.50 US$669,044
2015-03-20 2015-03-18 S Sale Novartis Bioventures Ltd Large shareholder
3,000 -0.1%
14.50
US$43,500 		3,000 -0.1% 14.50 US$43,500
2014-09-24 2014-09-22 B Purchase Apple Tree Partners II - Annex, L.P. Non-Executive Director Large shareholder
237,500 +7.1%
15.00
US$3,562,500 		237,500 +7.1% 15.00 US$3,562,500
2014-09-24 2014-09-22 B Purchase Novartis Bioventures Ltd Large shareholder
325,000 +7.5%
15.00
US$4,875,000 		325,000 +7.5% 15.00 US$4,875,000
2014-09-24 2014-09-22 B Purchase Harrison Seth Loring Non-Executive Director Large shareholder
362,500 +4.8%
15.00
US$5,437,500 		362,500 +4.8% 15.00 US$5,437,500
2014-09-24 2014-09-22 B Purchase Satter Muneer A Large shareholder
150,000 +9.2%
15.00
US$2,250,000 		150,000 +9.2% 15.00 US$2,250,000
2015-06-16 2014-06-15 S Sale Novartis Bioventures Ltd Large shareholder
14,777 -0.3%
14.20
US$209,833 		14,777 -0.3% 14.20 US$209,833
Explore more

More insider trading research around Eledon Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America